MedinCell S.A.
MedinCell S.A. (MDCLF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDCLF · as of Jun 9, 2026
Key Statistics
Explore MedinCell S.A. Data
mdclf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
mdclf competitorsMDCLF
AVCTF
BOVNF
CYDY
GSGTF
HLOSFStock Performance
Full HistoryAbout MedinCell S.A.
MedinCell S.A. is a pharmaceutical company dedicated to creating a diverse array of medical treatments. At the heart of its innovation is the BEPO platform, a unique technology designed for long-actin…
what is medincell s.a. · mdclf stock overview · medincell s.a. company profile · who is medincell s.a. ceo · mdclf OTC · medincell s.a. headquarters · medincell s.a. business segments
About Stock Overview & Key Data
MedinCell S.A. (MDCLF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 5, 2021. As of the latest trading session, MDCLF stock price is $34.39, with a market capitalization of $1.2B. The stock has returned +392.69% over the past 12 months and +392.69% year-to-date.
According to 1 Wall Street analysts, the consensus rating for MedinCell S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, MedinCell S.A. reported revenue of $25.5M and net income of -$18.4M. For detailed data — including MedinCell S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MedinCell S.A. (MDCLF) stock price is $34.39. The stock is traded on OTC under the ticker symbol MDCLF. The 52-week range is $6.98 – $34.39.